Autism Clinical Trial
— tRNS25112013Official title:
Transcranial Random Noise Noninvasive Brain Stimulation Applied to the Fronto-temporal Cortex Improves Verbal Fluency and Emphaty in Children With Autistic Spectrum Disorder
Verified date | April 2023 |
Source | Spanish Foundation for Neurometrics Development |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Interventional, prospective, randomized, double-blind, placebo-controlled and parallel assignment study, in which patients with Autism Spectrum Disorder (ASD) are two types of intervention by transcranial random noise stimulation (tRNS), to improve verbal fluency and empathy.
Status | Completed |
Enrollment | 225 |
Est. completion date | September 2014 |
Est. primary completion date | August 2014 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 5 Years to 12 Years |
Eligibility | Inclusion Criteria: - Patients between 5 and 12 years. - Meet DSM-IV criteria for autism spectrum disorder. - Patients who have been diagnosed at least 2 years before inclusion in the study. Exclusion Criteria: - Acute visual or hearing loss. - Traumatic brain injury. - Other neurological disorders: migraine, epilepsy, tuberous sclerosis ... - Trauma at birth. - Mental retardation. - Pregnancy. |
Country | Name | City | State |
---|---|---|---|
Spain | General Elche Hospital | Elche | Alicante |
Lead Sponsor | Collaborator |
---|---|
Spanish Foundation for Neurometrics Development |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Verbal Fluency | Goal: Improve in verbal fluency in ASD children between 5 and 12 years. We use D-KEFS (Delis-Kaplan Executive Function System Delis Kaplan Sorting Test), Verbal Fluency Subtest - Category Condition.
Description: The verbal fluency Category test evaluates fluent productivity in the verbal domain by asking participants to generate exemplars belonging to the category animals, and subsequently, boys´ names. Participants were given 60 s to do it. Values: Category scores were based on the average number of items generated in the two categories (animals and boys´names) during 60 s. Time Frame: Baseline (Before treatment) and 1 day Post-treatment (after completing 3 months of intensive speech therapy during tRNS sessions) |
During 3 months of intensive speech therapy during tRNS sessions | |
Primary | Sociability | Goal: Evaluate emphaty with CARS scale in autism spectrum disorder children between 5 and 12 years after tRNS sessions.
CARS (Childhood Autism Rating Scale) by Shopler & Reichler (1971) in Spanish version EVAI (Escala de Valoración de Autismo Infantil) by Leal-Soto, F.; Aguirre, L.P. y Williams, E.E. Description: 15 items in the scale that evaluate: Relating to people, Imitative Behavior, Emotional Response, Body Use, Object Use, Adaptation to Change, Visual Response, Listening Response, Perceptive Response, Fear or Anxiety, Verbal Communication, Non-Verbal Communication, Activity level, Level and consistency of Intellective Relations and General Impressions. Values: The CARS scores range from 15 to 60, with lower scores indicating better outcome. It classifies the child as not autistic (below 30), moderately autistic (30-36.5) or severely autistic (above 36.5) |
During 3 months of intensive speech therapy during tRNS sessions | |
Secondary | Ratio Theta/Beta Before tRNS | The purpose of the present study was to determine if the theta/beta ratio, and theta and beta separately, correlate with behavioral parameters, and if these measures discriminate between children a with Autism Spectrum disorder (ASD) and normal gender- and age-matched controls before and after tRNS intervention in ASD children between 5 and 12 years old. | During 3 months of intensive speech therapy during tRNS sessions | |
Secondary | Theta Amplitude in T5 Before tRNS | The purpose of the present study was to determine if the theta/beta ratio, and theta and beta separately, correlate with behavioral parameters, and if these measures discriminate between children a with Autism Spectrum disorder (ASD) and normal gender- and age-matched controls before and after tRNS intervention in ASD children between 5 and 12 years old. | During 3 months of intensive speech therapy during tRNS sessions | |
Secondary | Ratio Theta/Beta After tRNS | The purpose of the present study was to determine if the theta/beta ratio, and theta and beta separately, correlate with behavioral parameters, and if these measures discriminate between children a with Autism Spectrum disorder (ASD) and normal gender- and age-matched controls before and after tRNS intervention in ASD children between 5 and 12 years old. | During 3 months of intensive speech therapy during tRNS sessions | |
Secondary | Theta Amplitude in T5 After tRNS | Evaluate QEEG (brainwave changes in frequency bandfs and amplitude) after tRNS intervention in ASD children between 5 and 12 years old | During 3 months of intensive speech therapy during tRNS sessions | |
Secondary | Reaction Time in ECPT Before tRNS | ERP & Behaviour changes in ASD children after tRNS | During 3 months of intensive speech therapy during tRNS sessions | |
Secondary | Omission Errors Before tRNS | ERP and behaviour changes in ASD children before tRNS | During 3 months of intensive speech therapy during tRNS sessions | |
Secondary | Commission Errors Before tRNS | ERP and Behaviour changes in ASD children before tRNS | During 3 months of intensive speech therapy during tRNS sessions | |
Secondary | P3b Wave Amplitude Before tRNS | ERP and behaviour Changes in ASD children before tRNS | During 3 months of intensive speech therapy during tRNS sessions | |
Secondary | Reaction Time After tRNS | ERP and behaviour Changes in ASD children after tRNS | During 3 months of intensive speech therapy during tRNS sessions | |
Secondary | Ommision Errors After tRNS | ERP and behaviour Changes in ASD children after tRNS | During 3 months of intensive speech therapy during tRNS sessions | |
Secondary | Commission Errors After tRNS | ERP and behaviour Changes in ASD children after tRNS | During 3 months of intensive speech therapy during tRNS sessions | |
Secondary | P3b Wave Amplitude After tRNS | ERP and behaviour Changes in ASD children after tRNS | During 3 months of intensive speech therapy during tRNS sessions |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05302167 -
Molehill Mountain Feasibility Study.
|
N/A | |
Completed |
NCT04167839 -
Effects of Sensory Diets on Children's Sensory Processing Skills, Psychosocial Skills, and Classroom Engagement
|
N/A | |
Terminated |
NCT04049981 -
Investigation of Mechanisms of Action in Superpower Glass
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT06080087 -
Implementation Toolkit to Enhance EBP Among Marginalized Families
|
N/A | |
Recruiting |
NCT04107064 -
Achieving Steady Work Among Adults With Autism Through Specialized Employment Program
|
N/A | |
Completed |
NCT03206996 -
Exposure Therapy for Auditory Sensitivity in Autism
|
N/A | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Completed |
NCT05588570 -
Coaching Children With Anxiety and Autism Through Telehealth
|
N/A | |
Enrolling by invitation |
NCT06058104 -
Evaluating Efficacy of a Digital Game Therapeutic for Children With Autism
|
N/A | |
Completed |
NCT02911194 -
a2 Milk for Autism and Attention-deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Completed |
NCT02847182 -
Cord Blood Infusion for Children With Autism Spectrum Disorder
|
Phase 2 | |
Completed |
NCT03002363 -
The Effects of Video Modeling of Audiological Testing on Pediatric Patient Compliance
|
Phase 1 | |
Withdrawn |
NCT02414451 -
Trial of Propranolol in Adults and Adolescents With ASD and Predictors of Response
|
N/A | |
Completed |
NCT02708290 -
Mental Imagery Therapy for Autism (MITA) - an Early Intervention Computerized Language Training Program for Children With ASD
|
||
Completed |
NCT02536365 -
Sensory Integration Therapy in Autism: Mechanisms and Effectiveness
|
N/A | |
Completed |
NCT02508922 -
Trial of Vitamin D3 Supplementation in Paediatric Autism
|
N/A | |
Completed |
NCT02720900 -
Prebiotic Intervention for Autism Spectrum Disorders
|
N/A | |
Recruiting |
NCT01836562 -
A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Autism
|
Phase 1/Phase 2 | |
Recruiting |
NCT02255565 -
Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study
|
Phase 4 | |
Completed |
NCT02154828 -
Clinical Evaluation of Integrative Practices Units Infant and Child Care for Unit Children With Typical or Atypical Autism (AUTISM)
|